Table 2.
Adverse Events | n (%) |
---|---|
Total events | 134 |
Grade 3 or higher* | 21 (15·7%) |
Fever | 5 (3·7%) |
Headache | 3 (2·2%) |
Hematological events | 6 (4·5%) |
Increased WBC | 2 (1·5%) |
Neutropenia | 2 (1·5%) |
Thrombocytopenia | 2 (1·5%) |
Thrombocytosis | 1 (0·7%) |
Anemia | 1 (0·5%) |
Pruritis | 1 (0·5%) |
Neurological worsening due to PML | 25 (18·7%) |
Worsening of underlying disease | 10 (7·5%) |
Intercurrent illness | 21 (15·7%) |
no AE grade 3 or higher deemed treatment-related